AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...
Doctors in Delhi successfully treated liver cancer in a 72-year-old high-risk patient without surgery using a minimally invasive procedure. The cancer developed from long-ignored fatty liver disease ...
SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...
Efficacy and safety of second-line therapy by envafolimab combined with anlotinib and S-1 in pancreatic cancer patients: A single-arm, phase II clinical trial. This is an ASCO Meeting Abstract from ...
As many as three in five liver cancer cases could be prevented—with obesity-linked cases on the rise in particular. This is the finding of a report from the Lancet Commission on liver cancer, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results